Members |
acceptabilityId |
1A2 (UICC) |
Acceptable (foundation metadata concept) |
1A3 (AJCC) |
Acceptable (foundation metadata concept) |
1A3 (UICC) |
Acceptable (foundation metadata concept) |
1B |
Preferred (foundation metadata concept) |
1B (AJCC) |
Acceptable (foundation metadata concept) |
1B (UICC) |
Acceptable (foundation metadata concept) |
1B (qualifier value) |
Preferred (foundation metadata concept) |
1B1 (AJCC) |
Acceptable (foundation metadata concept) |
1B1 (UICC) |
Acceptable (foundation metadata concept) |
1B2 (AJCC) |
Acceptable (foundation metadata concept) |
1B2 (UICC) |
Acceptable (foundation metadata concept) |
1B3 (AJCC) |
Acceptable (foundation metadata concept) |
1B3 (UICC) |
Acceptable (foundation metadata concept) |
1C (AJCC) |
Acceptable (foundation metadata concept) |
1C (UICC) |
Acceptable (foundation metadata concept) |
1D cold incubation |
Acceptable (foundation metadata concept) |
1D post incubation |
Acceptable (foundation metadata concept) |
1D-1-guanidino-3-amino-1,3-dideoxy-scyllo-inositol aminotransferase |
Preferred (foundation metadata concept) |
1D-1-guanidino-3-amino-1,3-dideoxy-scyllo-inositol aminotransferase (substance) |
Preferred (foundation metadata concept) |
1D-myo-inositol-tetrakisphosphate 1-kinase |
Preferred (foundation metadata concept) |
1D-myo-inositol-tetrakisphosphate 1-kinase (substance) |
Preferred (foundation metadata concept) |
1D-myo-inositol-tetrakisphosphate 5-kinase |
Preferred (foundation metadata concept) |
1D-myo-inositol-tetrakisphosphate 5-kinase (substance) |
Preferred (foundation metadata concept) |
1D-myo-inositol-trisphosphate 3-kinase |
Preferred (foundation metadata concept) |
1D-myo-inositol-trisphosphate 3-kinase (substance) |
Preferred (foundation metadata concept) |
1D-myo-inositol-trisphosphate 5-kinase |
Preferred (foundation metadata concept) |
1D-myo-inositol-trisphosphate 5-kinase (substance) |
Preferred (foundation metadata concept) |
1D-myo-inositol-trisphosphate 6-kinase |
Preferred (foundation metadata concept) |
1D-myo-inositol-trisphosphate 6-kinase (substance) |
Preferred (foundation metadata concept) |
1E (AJCC) |
Acceptable (foundation metadata concept) |
1E (UICC) |
Acceptable (foundation metadata concept) |
1H post 100 g glucose PO |
Acceptable (foundation metadata concept) |
1H post 50 g glucose PO |
Acceptable (foundation metadata concept) |
1H post 75 g glucose PO |
Acceptable (foundation metadata concept) |
1H post dose corticotropin |
Acceptable (foundation metadata concept) |
1H post dose glucose |
Acceptable (foundation metadata concept) |
1H post incubation |
Acceptable (foundation metadata concept) |
1H post meal |
Acceptable (foundation metadata concept) |
1H post resting |
Acceptable (foundation metadata concept) |
1H-3-hydroxy-4-oxoquinoline 2,4-dioxygenase |
Acceptable (foundation metadata concept) |
1H-Benzotriazol |
Preferred (foundation metadata concept) |
1H-Benzotriazol |
Preferred (foundation metadata concept) |
1H-Benzotriazol (product) |
Preferred (foundation metadata concept) |
1H-Benzotriazol (substance) |
Preferred (foundation metadata concept) |
1H-Benzotriazole |
Acceptable (foundation metadata concept) |
1H-Pyrazole-3-ethanamine |
Acceptable (foundation metadata concept) |
1H-Pyrazole-3-ethanamine dihydrochloride |
Acceptable (foundation metadata concept) |
1L-myo-Inositol-1-phosphatase |
Preferred (foundation metadata concept) |
1L-myo-Inositol-1-phosphatase (substance) |
Preferred (foundation metadata concept) |
1S (AJCC) |
Acceptable (foundation metadata concept) |
1S (UICC) |
Acceptable (foundation metadata concept) |
1p partial monosomy |
Preferred (foundation metadata concept) |
1p partial monosomy (disorder) |
Preferred (foundation metadata concept) |
1p21.3 microdeletion syndrome |
Preferred (foundation metadata concept) |
1p21.3 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
1p21.3 microdeletion syndrome is an extremely rare chromosomal anomaly characterised by severe speech and language delay, intellectual deficiency, autism spectrum disorder. |
Preferred (foundation metadata concept) |
1p31p32 microdeletion syndrome |
Preferred (foundation metadata concept) |
1p31p32 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
1p31p32 microdeletion syndrome is a rare chromosomal anomaly syndrome, resulting from the partial deletion of the short arm of chromosome 1, characterised by developmental delay, corpus callosum agenesis/hypoplasia and craniofacial dysmorphism, such as macrocephaly (caused by hydrocephalus or ventriculomegaly), low-set ears, anteverted nostrils and micrognathia. Urinary tract defects (e.g. vesicoureteral reflux, urinary incontinence) are also frequently associated. Other reported variable manifestations include hypotonia, tethered spinal cord, Chiari type I malformation and seizures. |
Preferred (foundation metadata concept) |
1p35.2 microdeletion syndrome |
Preferred (foundation metadata concept) |
1p35.2 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
1p36 deletion syndrome |
Preferred (foundation metadata concept) |
1q partial monosomy |
Preferred (foundation metadata concept) |
1q partial monosomy (disorder) |
Preferred (foundation metadata concept) |
1q partial trisomy syndrome |
Preferred (foundation metadata concept) |
1q partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
1q21.1 contiguous gene deletion |
Acceptable (foundation metadata concept) |
1q21.1 microdeletion |
Preferred (foundation metadata concept) |
1q21.1 microdeletion syndrome |
Acceptable (foundation metadata concept) |
1q21.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
1q21.1 microduplication syndrome |
Preferred (foundation metadata concept) |
1q21.1 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
1q41-q42 microdeletion syndrome |
Acceptable (foundation metadata concept) |
1q41q42 microdeletion syndrome |
Preferred (foundation metadata concept) |
1q41q42 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
1q41q42 microdeletion syndrome is a chromosomal anomaly characterised by a severe developmental delay and/or intellectual disability, typical facial dysmorphic features, brain anomalies, seizures, cleft palate, clubfeet, nail hypoplasia and congenital heart disease. |
Preferred (foundation metadata concept) |
1q44 microdeletion syndrome |
Preferred (foundation metadata concept) |
1q44 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
1q44 microdeletion syndrome is a newly described syndrome associated with facial dysmorphism, developmental delay, in particular of expressive speech, seizures and hypotonia. |
Preferred (foundation metadata concept) |
1st |
Acceptable (foundation metadata concept) |
1st HiB and DTP vaccine given |
Preferred (foundation metadata concept) |
1st HiB and DTP vaccine given (situation) |
Preferred (foundation metadata concept) |
1st Hib and DTP vaccine given |
Preferred (foundation metadata concept) |
1st Japanese encephalitis vaccination |
Preferred (foundation metadata concept) |
1st Japanese encephalitis vaccination |
Preferred (foundation metadata concept) |
1st Japanese encephalitis vaccination (procedure) |
Preferred (foundation metadata concept) |
1st Japanese encephalitis vaccination (procedure) |
Preferred (foundation metadata concept) |
1st floor |
Acceptable (foundation metadata concept) |
1st heart sound split |
Acceptable (foundation metadata concept) |
1st hepatitis A junior vaccination |
Acceptable (foundation metadata concept) |
1st left lumbar vein |
Acceptable (foundation metadata concept) |
1st right lumbar vein |
Acceptable (foundation metadata concept) |
1st specimen |
Acceptable (foundation metadata concept) |
1st trimester |
Acceptable (foundation metadata concept) |
2 |
Preferred (foundation metadata concept) |
2 |
Preferred (foundation metadata concept) |
2 (AJCC) |
Acceptable (foundation metadata concept) |
2 (UICC) |
Acceptable (foundation metadata concept) |
2 (qualifier value) |
Preferred (foundation metadata concept) |
2 ASD - Secundum atrial septal defect |
Acceptable (foundation metadata concept) |
2 bulky (AJCC) |
Acceptable (foundation metadata concept) |